ROCHESTER HILLS, Michigan—InfuSystem Holdings, Inc. (NYSE American: INFU), a national health care service provider, facilitating outpatient care for durable medical equipment (DME) manufacturers and health care providers, announced it is set to join the broad-market Russell 3000 Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the U.S. market opens on June 26.
Annual Russell indexes reconstitution captures the 4,000 largest U.S. stocks as of April 28, ranking them by total market capitalization. Membership in the U.S. all-cap Russell 3000 Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000 Index or small-cap Russell 2000 Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
“We are excited to be included in the Russell 3000 Index, one of the most widely cited performance benchmarks," said Richard DiIorio, chief executive officer of InfuSystem. "This is another meaningful milestone for InfuSystem as we continue building on our positive momentum to drive future growth and deliver long-term value creation for our loyal shareholders.”
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $12.1 trillion in assets are benchmarked against Russell’s U.S. indexes. Russell indexes are part of FTSE Russell, a global index provider.
For more information on the Russell 3000®Index and the Russell Indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website.
